{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-040113","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.147098+00:00","generated_at":"2026-06-08T07:43:31.827511+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Biofrontera Q3 revenue doubles to $8.9M; net loss widens to $6.3M","bullets":["Total revenues $8.9M, up 106% YoY, driven by Ameluz adoption and price increase.","Net loss of $6.3M ($4.64 per share) vs net loss of $2.6M ($2.26 per share) in Q3 2022.","Cash and cash equivalents $3.4M; investment in Biofrontera AG shares valued at $3.3M.","Raised $4.5M in registered direct offering at-the-market on November 2, 2023.","Affirms FY2023 revenue growth at least 25% vs 2022; expects cash flow positive within ~1.5 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-040113","json":"https://secwatch.observer/filing/0001493152-23-040113.json","markdown":"https://secwatch.observer/filing/0001493152-23-040113.md","text":"https://secwatch.observer/filing/0001493152-23-040113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223040113/0001493152-23-040113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223040113/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:43:31.827511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"481a067ec4461f89a103e4e9a0ca874a1d9c7621","claim":"Biofrontera Inc. reported three and nine months ended September 30, 2023 results: revenue $8.9 million, net income $(4.64) per share, EPS $(4.64) per share. Guidance reaffirmed.","evidence_excerpt":"Total revenues for the third quarter of 2023 were $8.9 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223040113/0001493152-23-040113-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2023"},{"label":"Revenue","value":"$8.9 million"},{"label":"Net income","value":"$(4.64) per share"},{"label":"EPS","value":"$(4.64) per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}